HEADER TRANSFERASE/INHIBITOR 11-MAR-19 6O8I TITLE BTK IN COMPLEX WITH INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE BTK; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: AGAMMAGLOBULINEMIA TYROSINE KINASE,ATK,B-CELL PROGENITOR COMPND 6 KINASE,BPK,BRUTON TYROSINE KINASE; COMPND 7 EC: 2.7.10.2; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 SYNTHETIC: YES; SOURCE 3 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 4 ORGANISM_COMMON: HUMAN; SOURCE 5 ORGANISM_TAXID: 9606 KEYWDS PROTEIN KINASE, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR M.POKROSS,A.J.TEBBEN,S.H.WATTERSON REVDAT 2 24-APR-19 6O8I 1 JRNL REVDAT 1 03-APR-19 6O8I 0 JRNL AUTH S.H.WATTERSON,Q.LIU,M.BEAUDOIN BERTRAND,D.G.BATT,L.LI, JRNL AUTH 2 M.A.PATTOLI,S.SKALA,L.CHENG,M.T.OBERMEIER,R.MOORE,Z.YANG, JRNL AUTH 3 R.VICKERY,P.A.ELZINGA,L.DISCENZA,C.D'ARIENZO,K.M.GILLOOLY, JRNL AUTH 4 T.L.TAYLOR,C.PULICICCHIO,Y.ZHANG,E.HEIMRICH,K.W.MCINTYRE, JRNL AUTH 5 Q.RUAN,R.A.WESTHOUSE,I.M.CATLETT,N.ZHENG,C.CHAUDHRY,J.DAI, JRNL AUTH 6 M.A.GALELLA,A.J.TEBBEN,M.POKROSS,J.LI,R.ZHAO,D.SMITH, JRNL AUTH 7 R.RAMPULLA,A.ALLENTOFF,M.A.WALLACE,A.MATHUR,L.SALTER-CID, JRNL AUTH 8 J.E.MACOR,P.H.CARTER,A.FURA,J.R.BURKE,J.A.TINO JRNL TITL DISCOVERY OF BRANEBRUTINIB (BMS-986195): A STRATEGY FOR JRNL TITL 2 IDENTIFYING A HIGHLY POTENT AND SELECTIVE COVALENT INHIBITOR JRNL TITL 3 PROVIDING RAPID IN VIVO INACTIVATION OF BRUTON'S TYROSINE JRNL TITL 4 KINASE (BTK). JRNL REF J. MED. CHEM. V. 62 3228 2019 JRNL REFN ISSN 1520-4804 JRNL PMID 30893553 JRNL DOI 10.1021/ACS.JMEDCHEM.9B00167 REMARK 2 REMARK 2 RESOLUTION. 1.42 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : BUSTER 2.11.7 REMARK 3 AUTHORS : BRICOGNE,BLANC,BRANDL,FLENSBURG,KELLER, REMARK 3 : PACIOREK,ROVERSI,SHARFF,SMART,VONRHEIN, REMARK 3 : WOMACK,MATTHEWS,TEN EYCK,TRONRUD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.42 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 35.79 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 3 NUMBER OF REFLECTIONS : 53281 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.195 REMARK 3 R VALUE (WORKING SET) : 0.192 REMARK 3 FREE R VALUE : 0.222 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.210 REMARK 3 FREE R VALUE TEST SET COUNT : 4909 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 50 REMARK 3 BIN RESOLUTION RANGE HIGH (ANGSTROMS) : 1.42 REMARK 3 BIN RESOLUTION RANGE LOW (ANGSTROMS) : 1.43 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 96.71 REMARK 3 REFLECTIONS IN BIN (WORKING + TEST SET) : 1066 REMARK 3 BIN R VALUE (WORKING + TEST SET) : 0.2568 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 968 REMARK 3 BIN R VALUE (WORKING SET) : 0.2540 REMARK 3 BIN FREE R VALUE : 0.2869 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.19 REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2117 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 27 REMARK 3 SOLVENT ATOMS : 248 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 16.99 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 24.03 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.50480 REMARK 3 B22 (A**2) : -1.40540 REMARK 3 B33 (A**2) : 2.91030 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.200 REMARK 3 DPI (BLOW EQ-10) BASED ON R VALUE (A) : 0.069 REMARK 3 DPI (BLOW EQ-9) BASED ON FREE R VALUE (A) : 0.071 REMARK 3 DPI (CRUICKSHANK) BASED ON R VALUE (A) : 0.065 REMARK 3 DPI (CRUICKSHANK) BASED ON FREE R VALUE (A) : 0.068 REMARK 3 REMARK 3 REFERENCES: BLOW, D. (2002) ACTA CRYST D58, 792-797 REMARK 3 CRUICKSHANK, D.W.J. (1999) ACTA CRYST D55, 583-601 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.955 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.938 REMARK 3 REMARK 3 NUMBER OF GEOMETRIC FUNCTION TERMS DEFINED : 15 REMARK 3 TERM COUNT WEIGHT FUNCTION. REMARK 3 BOND LENGTHS : 2264 ; 2.000 ; HARMONIC REMARK 3 BOND ANGLES : 3074 ; 2.000 ; HARMONIC REMARK 3 TORSION ANGLES : 814 ; 2.000 ; SINUSOIDAL REMARK 3 TRIGONAL CARBON PLANES : NULL ; NULL ; NULL REMARK 3 GENERAL PLANES : 391 ; 5.000 ; HARMONIC REMARK 3 ISOTROPIC THERMAL FACTORS : 2264 ; 20.000 ; HARMONIC REMARK 3 BAD NON-BONDED CONTACTS : NULL ; NULL ; NULL REMARK 3 IMPROPER TORSIONS : NULL ; NULL ; NULL REMARK 3 PSEUDOROTATION ANGLES : NULL ; NULL ; NULL REMARK 3 CHIRAL IMPROPER TORSION : 280 ; 5.000 ; SEMIHARMONIC REMARK 3 SUM OF OCCUPANCIES : NULL ; NULL ; NULL REMARK 3 UTILITY DISTANCES : NULL ; NULL ; NULL REMARK 3 UTILITY ANGLES : NULL ; NULL ; NULL REMARK 3 UTILITY TORSION : NULL ; NULL ; NULL REMARK 3 IDEAL-DIST CONTACT TERM : 2903 ; 4.000 ; SEMIHARMONIC REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.010 REMARK 3 BOND ANGLES (DEGREES) : 0.96 REMARK 3 PEPTIDE OMEGA TORSION ANGLES (DEGREES) : 3.41 REMARK 3 OTHER TORSION ANGLES (DEGREES) : 16.15 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6O8I COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-MAR-19. REMARK 100 THE DEPOSITION ID IS D_1000240066. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 23-APR-15 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06DA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.987 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS PILATUS 2M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 53282 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.420 REMARK 200 RESOLUTION RANGE LOW (A) : 59.510 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.8 REMARK 200 DATA REDUNDANCY : 2.300 REMARK 200 R MERGE (I) : 0.05100 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 11.2000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.42 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 97.0 REMARK 200 DATA REDUNDANCY IN SHELL : 2.30 REMARK 200 R MERGE FOR SHELL (I) : 0.44400 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.100 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 48.53 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.39 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: UNKOWN, VAPOR DIFFUSION, TEMPERATURE REMARK 280 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X+1/2,Y+1/2,-Z REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 36.06550 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 52.66700 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 36.06550 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 52.66700 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: MONOMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 434 REMARK 465 GLY A 435 REMARK 465 SER A 436 REMARK 465 MET A 437 REMARK 465 SER A 438 REMARK 465 GLU A 439 REMARK 465 ASP A 440 REMARK 465 GLU A 441 REMARK 465 SER A 659 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A 406 CG CD CE NZ REMARK 470 GLN A 412 CG CD OE1 NE2 REMARK 470 LYS A 433 CG CD CE NZ REMARK 470 GLU A 444 CG CD OE1 OE2 REMARK 470 LYS A 447 CG CD CE NZ REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 ARG A 468 CG CD NE CZ NH1 NH2 REMARK 480 GLU A 608 CD OE1 OE2 REMARK 480 GLU A 658 CD OE1 OE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 520 -9.81 77.78 REMARK 500 ASP A 521 47.91 -144.05 REMARK 500 SER A 538 -155.21 -129.80 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: binding site for residue LTJ A 4000 DBREF 6O8I A 391 659 UNP Q06187 BTK_HUMAN 391 659 SEQRES 1 A 269 GLY TYR GLY SER TRP GLU ILE ASP PRO LYS ASP LEU THR SEQRES 2 A 269 PHE LEU LYS GLU LEU GLY THR GLY GLN PHE GLY VAL VAL SEQRES 3 A 269 LYS TYR GLY LYS TRP ARG GLY GLN TYR ASP VAL ALA ILE SEQRES 4 A 269 LYS MET ILE LYS GLU GLY SER MET SER GLU ASP GLU PHE SEQRES 5 A 269 ILE GLU GLU ALA LYS VAL MET MET ASN LEU SER HIS GLU SEQRES 6 A 269 LYS LEU VAL GLN LEU TYR GLY VAL CYS THR LYS GLN ARG SEQRES 7 A 269 PRO ILE PHE ILE ILE THR GLU TYR MET ALA ASN GLY CYS SEQRES 8 A 269 LEU LEU ASN TYR LEU ARG GLU MET ARG HIS ARG PHE GLN SEQRES 9 A 269 THR GLN GLN LEU LEU GLU MET CYS LYS ASP VAL CYS GLU SEQRES 10 A 269 ALA MET GLU TYR LEU GLU SER LYS GLN PHE LEU HIS ARG SEQRES 11 A 269 ASP LEU ALA ALA ARG ASN CYS LEU VAL ASN ASP GLN GLY SEQRES 12 A 269 VAL VAL LYS VAL SER ASP PHE GLY LEU SER ARG TYR VAL SEQRES 13 A 269 LEU ASP ASP GLU TYR THR SER SER VAL GLY SER LYS PHE SEQRES 14 A 269 PRO VAL ARG TRP SER PRO PRO GLU VAL LEU MET TYR SER SEQRES 15 A 269 LYS PHE SER SER LYS SER ASP ILE TRP ALA PHE GLY VAL SEQRES 16 A 269 LEU MET TRP GLU ILE TYR SER LEU GLY LYS MET PRO TYR SEQRES 17 A 269 GLU ARG PHE THR ASN SER GLU THR ALA GLU HIS ILE ALA SEQRES 18 A 269 GLN GLY LEU ARG LEU TYR ARG PRO HIS LEU ALA SER GLU SEQRES 19 A 269 LYS VAL TYR THR ILE MET TYR SER CYS TRP HIS GLU LYS SEQRES 20 A 269 ALA ASP GLU ARG PRO THR PHE LYS ILE LEU LEU SER ASN SEQRES 21 A 269 ILE LEU ASP VAL MET ASP GLU GLU SER HET LTJ A4000 27 HETNAM LTJ 4-[(3S)-3-{[(2E)-BUT-2-ENOYL]AMINO}PIPERIDIN-1-YL]-5- HETNAM 2 LTJ FLUORO-2,3-DIMETHYL-1H-INDOLE-7-CARBOXAMIDE FORMUL 2 LTJ C20 H25 F N4 O2 FORMUL 3 HOH *248(H2 O) HELIX 1 AA1 TYR A 392 GLU A 396 5 5 HELIX 2 AA2 ASP A 398 LYS A 400 5 3 HELIX 3 AA3 ILE A 443 LEU A 452 1 10 HELIX 4 AA4 CYS A 481 GLU A 488 1 8 HELIX 5 AA5 MET A 489 ARG A 492 5 4 HELIX 6 AA6 GLN A 494 LYS A 515 1 22 HELIX 7 AA7 ALA A 523 ARG A 525 5 3 HELIX 8 AA8 LEU A 542 LEU A 547 1 6 HELIX 9 AA9 ASP A 549 SER A 554 1 6 HELIX 10 AB1 PRO A 560 SER A 564 5 5 HELIX 11 AB2 PRO A 565 SER A 572 1 8 HELIX 12 AB3 SER A 575 SER A 592 1 18 HELIX 13 AB4 THR A 602 GLN A 612 1 11 HELIX 14 AB5 SER A 623 CYS A 633 1 11 HELIX 15 AB6 LYS A 637 ARG A 641 5 5 HELIX 16 AB7 THR A 643 GLU A 658 1 16 SHEET 1 AA1 5 LEU A 402 GLY A 411 0 SHEET 2 AA1 5 GLY A 414 TRP A 421 -1 O TYR A 418 N LYS A 406 SHEET 3 AA1 5 TYR A 425 ILE A 432 -1 O ILE A 429 N LYS A 417 SHEET 4 AA1 5 PHE A 471 GLU A 475 -1 O ILE A 472 N LYS A 430 SHEET 5 AA1 5 LEU A 460 CYS A 464 -1 N GLY A 462 O ILE A 473 SHEET 1 AA2 2 CYS A 527 VAL A 529 0 SHEET 2 AA2 2 VAL A 535 VAL A 537 -1 O LYS A 536 N LEU A 528 LINK SG CYS A 481 C19 LTJ A4000 1555 1555 1.77 CISPEP 1 ARG A 468 PRO A 469 0 0.37 SITE 1 AC1 14 ALA A 428 THR A 474 GLU A 475 TYR A 476 SITE 2 AC1 14 MET A 477 ALA A 478 GLY A 480 CYS A 481 SITE 3 AC1 14 ASN A 484 VAL A 546 LEU A 547 HOH A4102 SITE 4 AC1 14 HOH A4119 HOH A4205 CRYST1 72.131 105.334 38.052 90.00 90.00 90.00 P 21 21 2 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.013864 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009494 0.000000 0.00000 SCALE3 0.000000 0.000000 0.026280 0.00000